[Cardiotoxicity relatively common in cancer treatment].
Modern cancer therapy has noticeably improved the prognosis for various cancer diseases, but cardiovascular side effects are not uncommon, both in short and long term. The individual patient's cardiovascular risk profile affects the risk of developing side effects. Potential underestimation of this risk can lead to life-long severe cardiac disease for a patient that has been cured from cancer. Overestimation of the risk can lead to withdrawal of life-saving cancer treatment because of potentially reversible or mild cardiac side effects. A multidisciplinary approach will lead to better handling of cardio-oncologic patients.
Triemli Hospital - Cardiology Department Zürich, Switzerland - Stockholm, Sweden.
Eva
E
Bühlmann Lerjen
University Hospital Linköping - Cardiology Department Linköping, Sweden University Hospital Linköping - Cardiology Department Linköping, Sweden.
Laila
L
Hübbert
Karolinska Universitetssjukhuset - Onkologiska kliniken Stockholm, Sweden Karolinska University Hospital - Oncology Department Stockholm, Sweden.
Antroula
A
Papakonstantinou
Karolinska Universitetssjukhuset - Onkologiska kliniken Stockholm, Sweden Karolinska Insitute - Department of Oncology-Pathology Stockholm, Sweden.
Elham
E
Hedayati
Karolinska Universitets Sjukhuset - Hjärtkliniken Stockholm, Sweden Karolinska University Hospital - Cardiology Stockholm, Sweden.
Cecilia
C
Linde
Karolinska Institutet - Department of Molecular Medicine and Surgery Stockholm, Sweden Karolinska Institutet - Department of Medicine Stockholm, Sweden.
Agneta
A
Månsson Broberg
D000970:Antineoplastic Agents / Q000009:adverse effects*; D066126:Cardiotoxicity / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D007400:Interprofessional Relations; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors
D000970:Antineoplastic Agents